<DOC>
	<DOCNO>NCT00511420</DOCNO>
	<brief_summary>The purpose study evaluate effect optimize composition chocolate include natural ingredient demonstrate biological activity observe cardioprotectores effect human .</brief_summary>
	<brief_title>Effects Cocoa Products Cardiovascular Disease Risk Factors</brief_title>
	<detailed_description>Studies carry last decade demonstrate conclusive form food like nut , product like cocoa ingredient , consume isolated form take several integrate diet contribute prevention treatment cardiovascular disease . The study randomize , control , double-blind , parallel multi-center study 4 different type cocoa product [ 1 ) cocoa ingredient ( sugar vegetal oil ) , 2 ) cocoa plus hazelnuts ingredient , 3 ) 2 plus ingredient 4 ) cocoa , hazelnuts ingredient call ( LMN ) ] , introduce calorie-balanced diet 4 week prior stabilization period 2 week participant receive cocoa product type 1 . Cocoa product type 1 control type 2 , type 1 2 control type 3 4 . Cocoa product type 4 registered patent . The trial conduct Reus 3 city Catalonia ( Alcover , Centelles Vic ) ( Spain ) .</detailed_description>
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<criteria>Eligible participant systolic blood pressure ( BP ) 120 159 mm Hg diastolic blood pressure 80 99 mm Hg . This range include participant prehypertension ( systolic , 120139 mm Hg diastolic , 8089 mm Hg ) stage 1 hypertension ( systolic , 140159 mm Hg diastolic , 9099 mm Hg ) . Moreover , participant ' plasma LDLcholesterol concentration ≥ 3.35 mmol/L ( ≥ 130 ≤ 189 mg/dL ) triglyceride concentration &lt; 4 mmol/L ( 350 mg/dL ) fast state least one CVD risk factor age ( men ≥45 year ; woman ≥55 year ) , cigarette smoking , low high density lipoprotein cholesterol concentration ( &lt; 1.0 mmol/L ( 40 mg/dL ) &lt; 1,18 mmol/L ( 46 mg/dL ) , men woman , respectively ) , family history premature CVD ( male firstdegree relative &lt; 55 year age , female firstdegree relative &lt; 65 year age . Assessed medical history complete physical examination , plasma triglyceride concentration ≥4 mmol/L ( 350 mg/dL ) , BMI &gt; 35 kg/m2 , CVD clinical event , use lipidlowering drug least 2 month prior start study , diabetes mellitus ( least 2 fast glucose ≥7.0 mmol/L ( ≥ 126 mg/dL ) , renal insufficiency , thyroid endocrine disease .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>August 2007</verification_date>
	<keyword>cocoa</keyword>
	<keyword>cardiovascular disease</keyword>
	<keyword>blood pressure</keyword>
</DOC>